Kosea S. Frederick

Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats

Young Jin Moon, Kazuko Sagawa, Kosea S. Frederick et al. · The AAPS Journal · 2006 · 103 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug

Jonathan Bauman, Kosea S. Frederick, Aarti Sawant et al. · Drug Metabolism and Disposition · 2008 · 83 citations

Medicine, Pharmacology, Toxicology +17

NADPH-Dependent Covalent Binding of [³H]Paroxetine to Human Liver Microsomes and S-9 Fractions: Identification of an Electrophilic Quinone Metabolite of Paroxetine

Sabrina X. Zhao, Deepak Dalvie, Joan M. Kelly et al. · Chemical Research in Toxicology · 2007 · 82 citations

Medicine, Pharmacokinetics, Pharmacology +17

CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE−/− mice

Robert J. Aiello, Bret D. Perry, Patricia-Ann K. Bourassa et al. · Atherosclerosis · 2009 · 46 citations

Life Sciences, Cardiology, Immunology +17

N-(3,4-dimethoxyphenethyl)-4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2[1H]-yl)-6,7-dimethoxyquinazolin-2-amine (CP-100,356) as a “chemical knock-out equivalent” to assess the impact of efflux transporters on oral drug absorption in the rat

Amit S. Kalgutkar, Kosea S. Frederick, Bo Feng et al. · Journal of Pharmaceutical Sciences · 2009 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16